Randall Kaye - Net Worth and Insider Trading
Randall Kaye Net Worth
The estimated net worth of Randall Kaye is at least $1 Million dollars as of 2024-09-20. Randall Kaye is the CMO of Longboard Pharmaceuticals Inc and owns about 17,920 shares of Longboard Pharmaceuticals Inc (LBPH) stock worth over $607,309. Randall Kaye is also the Chief Medical Officer of Axsome Therapeutics Inc and owns about 6,022 shares of Axsome Therapeutics Inc (AXSM) stock worth over $577,148. Details can be seen in Randall Kaye's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Randall Kaye has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Randall Kaye
Randall Kaye Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Randall Kaye owns 2 companies in total, including Axsome Therapeutics Inc (AXSM) , and Longboard Pharmaceuticals Inc (LBPH) .
Click here to see the complete history of Randall Kaye’s form 4 insider trades.
Insider Ownership Summary of Randall Kaye
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | 2015-12-23 | Chief Medical Officer |
| LBPH | Longboard Pharmaceuticals Inc | 2024-08-12 | CMO |
Randall Kaye Latest Holdings Summary
Randall Kaye currently owns a total of 2 stocks. Among these stocks, Randall Kaye owns 17,920 shares of Longboard Pharmaceuticals Inc (LBPH) as of September 16, 2024, with a value of $607,309 and a weighting of 51.27%. Randall Kaye also owns 6,022 shares of Axsome Therapeutics Inc (AXSM) as of December 23, 2015, with a value of $577,148 and a weighting of 48.73%.
Latest Holdings of Randall Kaye
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LBPH | Longboard Pharmaceuticals Inc | 2024-09-16 | 17,920 | 33.89 | 607,309 |
| AXSM | Axsome Therapeutics Inc | 2015-12-23 | 6,022 | 95.84 | 577,148 |
Holding Weightings of Randall Kaye
Randall Kaye Form 4 Trading Tracker
According to the SEC Form 4 filings, Randall Kaye has made a total of 3 transactions in Longboard Pharmaceuticals Inc (LBPH) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Longboard Pharmaceuticals Inc is the sale of 16,666 shares on September 16, 2024, which brought Randall Kaye around $527,312.
According to the SEC Form 4 filings, Randall Kaye has made a total of 0 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years. The most-recent trade in Axsome Therapeutics Inc is the acquisition of 1,000 shares on December 23, 2015, which cost Randall Kaye around $9,030.
Insider Trading History of Randall Kaye
- 1
Randall Kaye Trading Performance
GuruFocus tracks the stock performance after each of Randall Kaye's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randall Kaye is -10.61%. GuruFocus also compares Randall Kaye's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randall Kaye within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Randall Kaye's insider trading performs compared to the benchmark.
Performance of Randall Kaye
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.62 | | | | | |
| Relative Return to S&P 500(%) | 14.13 | | | | | |
Randall Kaye Ownership Network
Randall Kaye Owned Company Details
What does Axsome Therapeutics Inc do?
Who are the key executives at Axsome Therapeutics Inc?
Randall Kaye is the Chief Medical Officer of Axsome Therapeutics Inc. Other key executives at Axsome Therapeutics Inc include Chief Operating Officer Mark L. Jacobson , General Counsel Hunter R. Murdock , and Chief Financial Officer Nick Pizzie .
Axsome Therapeutics Inc (AXSM) Insider Trades Summary
Over the past 18 months, Randall Kaye made no insider transaction in Axsome Therapeutics Inc (AXSM). Other recent insider transactions involving Axsome Therapeutics Inc (AXSM) include a net sale of 80,311 shares made by Mark L. Jacobson , a net sale of 40,085 shares made by Mark Coleman , and a net sale of 32,323 shares made by Roger Jeffs .
In summary, during the past 3 months, insiders sold 58,755 shares of Axsome Therapeutics Inc (AXSM) in total and bought 0 shares, with a net sale of 58,755 shares. During the past 18 months, 163,735 shares of Axsome Therapeutics Inc (AXSM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 163,735 shares.
Axsome Therapeutics Inc (AXSM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axsome Therapeutics Inc Insider Transactions
Randall Kaye Mailing Address
Above is the net worth, insider trading, and ownership report for Randall Kaye. You might contact Randall Kaye via mailing address: 11388 Sorrento Valley Road, Ste. 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
